John L. Flavin serves as Executive at Advanced Life Sciences Holdings, Inc., where they oversee executive responsibilities. Since joining the company, John L. Flavin has executed 5 insider transactions totaling $1.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 26, 2024 involved receiving (via award) 35,219 shares valued at $0.
John L. Flavin currently holds 413,015 shares of Advanced Life Sciences Holdings, Inc. (ADLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John L. Flavin has been a net buyer of ADLS stock. They have purchased $1.1K and sold $0 worth of shares.
John L. Flavin's most recent insider trade was on Mar 26, 2024, when they sold 35,219 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 31, 2022 | PYXS | $0 | Award | 66,831 | $N/A | Discretionary |
| Oct 13, 2021 | PYXS | $0 | Conversion | 2,388 | $N/A | Discretionary |
| Feb 27, 2008 | ADLS | $1.1K | Purchase | 1,200 | $0.91 | Discretionary |